Displaying drugs 1301 - 1325 of 1417 in total
Renzapride
Renzapride is currently in Phase III clinical development in the United States for the treatment of constipation-predominant irritable bowel syndrome (IBS-C). It has been suggested that renzapride is effective in the treatment of irritable bowel syndrome with alternating stool pattern. It is being developed by Alizyme of the UK.
Investigational
PRX-08066
Investigational
Meclinertant
Investigational
Fluralaner
Experimental
Vet approved
AZD-1981
AZD1981 has been used in trials studying the treatment and basic science of Asthma, Postmenopausal, Pharmakokinetic, Asthma Patients, and Drug Interaction, among others.
Investigational
BMS-777607
BMS-777607 has been investigated for the basic science of Malignant Solid Tumour.
Investigational
Vidupiprant
Vidupiprant has been used in trials studying the treatment and basic science of Asthma.
Investigational
SAR-405838
SAR405838 has been used in trials studying the treatment of Neoplasm Malignant.
Investigational
SP2456
Experimental
Tonabersat
Investigational
Glafenine
An anthranilic acid derivative with analgesic properties used for the relief of all types of pain. Glafenine is withdrawn from the American market.
Withdrawn
Displaying drugs 1301 - 1325 of 1417 in total